Key result
In a large registry of 8,101 patients, pericardiocentesis had a low overall complication rate of 1.42%, though mortality at 2 years was 68.5% primarily driven by underlying malignancies.
Answers are grounded in this paper and cite their sources.
Echo- and fluoroscopy-guided pericardiocentesis is a safe and essential procedure, though complication risks are elevated when performed following catheter-based cardiac interventions.
The term pericardiocentesis results from the combination of three ancient Greek words, namely ‘peri' (around), ‘cardia' (heart) and ‘centesis' (puncture), and refers to the puncture of the pericardium in order to aspirate pericardial fluid. Percutaneous pericardiocentesis was introduced in clinical practice in 1840 by the Austrian surgeon Frank Schuh, who introduced a trocar through the forth intercostal space in a young woman [1]. Since then, pericardiocentesis techniques have evolved with respect to both efficacy and safety issues, and have become increasingly common.Pericardiocentesis is currently applied either as an emergent therapeutic option in cases with hemodynamic instability due to cardiac tamponade, or as an elective procedure for diagnostic purposes in large and percutaneously accessible effusions [2,3]. Specifically, according to the most recent guidelines of the European Society of Cardiology on the diagnosis and management of pericardial diseases, pericardiocentesis has a class IB indication for cardiac tamponade and a class IIaB indication for large effusions (>20 mm in diastole), especially if persisting and in the absence of a definite underlying diagnosis [3,4]. Suspected bacterial or neoplastic pericarditis should reduce the physician's threshold for pericardiocentesis, provided that this is technically feasible [5].The fear of complications is a matter of concern and is seriously taken into account when pericardiocentesis is considered. Indeed, similarly to all needle procedures, the procedure may result in complications, including life-threatening ones, namely cardiac muscle perforation, puncture of the coronary arteries and left internal mammary artery, hemothorax, pneumopericardium, arrhythmias and infections (mediastinitis, abscess, purulent pericarditis, etc.), and puncture of the pericardial cavity or viscera [4,6], among others. Historically, the rate of morbidity and mortality associated to the blind procedure was unacceptably high at 50 and 6%, respectively. It is evident that, although in in the specific context of emergencies, the latter rates could be acceptable in the absence of valuable alternative treatment options, they are quite prohibitive for elective procedures [7]. Fortunately, in recent years, the institution of ultrasound- and/or fluoroscopy-guided pericardiocentesis has contributed to a dramatic reduction in the rate of complications. In particular, echocardiographic guidance allows localization of the most appropriate site to puncture, which corresponds to the closest distance between chest wall and the largest amount of fluid. With this method, other sites beyond the standard subxiphoid route may be used, such as the parasternal and apical approach [6]. In addition, echo-guided procedures may allow the accomplishment of the procedure at the bedside when cardiac catheterization facilities are not available, or in the context of an emergency. Thus, in the hands of qualified operators and with the use of the above-mentioned options, the complication rates attributed to pericardiocentesis have been dramatically reduced. In particular, in relevant large echocardiographic series, the rate of major complications ranged from 1.3 to 1.6%, whereas in fluoroscopy-guided procedures the respective rate was approximately 1% [4]. It should be emphasized that contraindications to pericardiocentesis include aortic dissection, myocardial rupture, uncorrected coagulopathy, anticoagulant therapy and severe thrombocytopenia [4,7]. However, any decision in this situation should be tailored to the individual patient and the facilities available on-site. In the study conducted by Ming-Yun Ho et al. [8 ]published in this issue of Cardiology, the authors sought to identify risk factors for complications, mortality and the need for reintervention in patients undergoing pericardiocentesis. This is a large-scale study including and following-up in the long term 8,101 patients undergoing 8,565 pericardiocenteses. In line with previous studies, in the era of echo- (or fluoroscopy-) guided pericardiocentesis, the overall complication rate was quite low at 1.42%. However, this rate increased to 3.7% with pericardiocentesis performed in the context of a catheter-based procedure, a finding which gains particular importance in view of the continuously growing number of the latter types of intervention reported worldwide. In particular, in recent studies based in the western world, the rate of pericardiocentesis complications following catheter procedures account for up to 24% of the total number of pericardiocentesis [9]. This rate is approaching the respective rate for malignancies (i.e. ∼34%), which has been traditionally reported as the most common underlying cause for the requirement of pericardiocentesis [4,9]. The rate of pericardiocentesis upon catheter-based cardiac procedures was also shown to increase in the study from Taiwan [8], from 14.4% between 1997 and 2000 to 16.2% between 2006 and 2010 (p < 0.001). A plausible explanation for the higher incidence of complications in the setting of catheter-based cardiac procedures is offered by the substantial proportion of patients being anticoagulated during the latter interventions [9]. On the other hand, catheter-related cardiac interventions have been associated with a significantly decreased risk of all-cause death (hazard ratio = 0.89). Regarding the rest of the study findings and in line with previous studies, among the various underlying pathologies, malignancies had the highest probability of requiring an additional pericardiocentesis during follow-up (hazard ratio = 2.2). Moreover, it is also worth reporting from this registry the poor outcome observed in patients subjected to pericardiocentesis, which was measured as 68.5% overall mortality in an approximately 2-year mean follow-up period. The high rate of mortality was mainly driven by the high rate of patients requiring pericardiocentesis due to malignancy. In this context, the above-mentioned mortality rate should be interpreted with caution and probably does not apply to populations where infectious causes (e.g. tuberculosis) are the prevailing underlying pathologies in patients requiring pericardiocentesis. Pericardiocentesis is currently celebrating its 175th anniversary. Today it is established in everyday clinical practice as both a life-saving procedure in cardiac tamponade and an inestimable diagnostic tool in significant pericardial effusions. However, there is still room for improvement both in terms of efficacy and safety. Regarding safety, it is of paramount importance to discriminate between patients requiring an immediate intervention and those who can be treated on a more selective basis, and probably transferred to specialized centers. This management strategy is expected to reduce the complication rate related to the procedure. In this context, a step-wise scoring system has been recently developed by the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, in a relevant position statement paper [10]. However, the above-mentioned approach needs a prospective validation prior to its widespread application in daily practice. Last but not least, several issues need to be addressed to improve the performance of the procedure in the short term. For instance, no data are currently available regarding the usefulness of extended pericardial drainage in nonmalignant nonbacterial effusions in terms of effusion recurrence, which is a frequent and troublesome complication of pericarditis [3,11]. This issue is currently being tested in the DROP multicenter randomized trial [12], the results of which are expected in the near feature. We conclude that, in the presence of significant pericardial effusion, pericardiocentesis should be applied in cases of life-threatening hemodynamic compromise or in cases where a specific cause of pericarditis is highly probable but diagnosis cannot be established by other means. In the decision making of physicians performing pericardiocentesis, the phrase ‘primum non nocere' should always be kept in mind.The authors declare no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Lazaros et al. (2014) conducted an editorial in Pericardial effusion requiring pericardiocentesis (n=8,101). Pericardiocentesis was evaluated on Complications, mortality, and the need for reintervention. In a large registry of 8,101 patients, pericardiocentesis had a low overall complication rate of 1.42%, though mortality at 2 years was 68.5% primarily driven by underlying malignancies.
Synapse has enriched 10 related papers. Consider them for comparative context: